Companies: 10,795·Total market cap: $144.5T
Braskem S.A.

Braskem S.A.

BAKNYSEBasic Materials● Active
$3.55
+$0.07(+1.87%)
Market Cap$1.4B
P/E Ratio
52W High$5.395
52W Low$2.32
Overview

Braskem S.A. (BAK) · Income Statement

Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.

FMP · BAK · as of 2026-06-08

Financial statements

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$69.33B$77.41B$70.57B$96.52B$105.63B
Cost of Revenue$67.80B$71.41B$67.55B$85.16B$73.57B
Gross Profit$1.53B$6.00B$3.02B$11.36B$32.06B
Gross Margin %(computed)2.20%7.75%4.28%11.77%30.35%
Operating Expenses
R&D Expenses$0.45B$0.46B$0.38B$0.37B$0.30B
G&A Expenses$2.62B$2.64B$2.47B$2.76B$2.52B
Total Operating Expenses$5.48B$4.99B$4.77B$5.25B$4.88B
Operating Income($3.95B)$1.01B($1.75B)$6.11B$27.18B
Operating Margin %(computed)-5.70%1.31%-2.48%6.33%25.73%
Interest Income$0.71B$1.26B$0.87B$1.05B$0.44B
Interest Expense$5.82B$5.44B$4.78B$3.33B$3.19B
Income Before Tax($2.79B)($17.73B)($6.19B)$0.05B$17.96B
Income Tax Expense$7.96B($5.68B)($1.30B)$0.87B$4.00B
Net Income($9.69B)($11.32B)($4.58B)($0.34B)$13.98B
Net Margin %(computed)-13.97%-14.62%-6.49%-0.35%13.24%
Per Share & EBITDA
EPS (Basic)$-24.32$-28.40$-11.50$-2.06$35.12
Wtd Avg Shares0.40B0.40B0.40B0.40B0.40B
EBITDA$0.63B$2.70B$3.26B$8.11B$25.33B
EBITDA Margin %(computed)0.91%3.48%4.63%8.40%23.98%

Data source: Financial Modeling Prep · Last updated: 2026-06-08 · BRL · B

Explore more Braskem S.A. data

About Braskem S.A. (BAK) Income Statement

Braskem S.A. (BAK) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, BAK reported revenue of $69.33B, gross profit of $1.53B (gross margin 2.20%), and net income of ($9.69B) — a net profit margin of -13.97%.

Frequently asked questions

BAK · 4 questions

Braskem S.A. (BAK) reported revenue of $69.33B for 2025, down 10.4% year-over-year.

BAK revenueBAK salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08